Post Holdings (POST) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 net sales rose 5% to $1.95 billion, with operating profit up 28% to $203 million and net earnings up 11% to $100 million, driven by acquisitions and improved margins.
Adjusted EBITDA for Q3 was $350.2 million, up 3.5% year-over-year; diluted EPS was $1.53, up from $1.38.
Strong performance in branded/private label cereal, pet business, and value-added eggs; recent acquisitions contributed positively.
Aggressive share repurchases and historically low leverage position support strategic flexibility.
Completed acquisitions of Perfection Pet Foods, Deeside Cereals, and Smucker's pet food business, expanding pet food and UK cereal businesses.
Financial highlights
Q3 consolidated net sales were $1.95 billion, up 5% year-over-year, driven by acquisitions; excluding acquisitions, sales declined.
Adjusted EBITDA was $350.2 million; segment-adjusted EBITDA increased 27.8% in Post Consumer Brands and 23.9% in Weetabix versus prior year.
Gross profit margin improved to 29.6% in Q3, up from 27.0% a year ago; gross profit was $577.3 million.
Cash from operations increased to $696 million for the nine months; ended the quarter with $334 million in cash and $6.4 billion in long-term debt.
Repurchased 2.5 million shares for $255 million and issued $1 billion in new senior secured notes.
Outlook and guidance
Raised full-year 2024 Adjusted EBITDA guidance to $1,370–$1,390 million.
Expect a more stable consumer environment in 2025, supporting favorable volume trends.
Foodservice-adjusted EBITDA expected at ~$100 million in Q4, with ongoing run rate around $105 million.
Lancaster plant closure to contribute $25 million to EBITDA in fiscal 2025.
CapEx for 2025 expected to be similar to 2024, with ongoing investments in pet food and egg capacity.
Latest events from Post Holdings
- FY24 delivered robust EBITDA and cash flow; FY25 guidance projects continued growth.POST
Q4 20248 Jul 2026 - Q2 net sales up 4.7%, operating profit up 16%, and share count cut 15% amid portfolio changes.POST
Q2 20268 May 2026 - Net sales up 10.1%, Adjusted EBITDA up 13.1%, and full-year outlook raised.POST
Q1 20269 Apr 2026 - Q3 Adjusted EBITDA up 13.4%, FY25 guidance raised, and acquisitions drive growth.POST
Q3 202527 Jan 2026 - Acquisition of 8th Avenue for $880M boosts category depth and free cash flow accretion.POST
M&A Presentation27 Jan 2026 - Q1 net earnings up 28.6% to $113.3M, with raised 2025 EBITDA guidance and strong share repurchases.POST
Q1 202523 Dec 2025 - Virtual annual meeting to vote on directors, auditor, pay, and supermajority rule changes.POST
Proxy Filing15 Dec 2025 - Shareholders will vote on director elections, auditor ratification, executive pay, and governance reforms.POST
Proxy Filing15 Dec 2025 - Shareholders to vote on board, auditor, compensation, incentive plan, and governance reforms.POST
Proxy Filing1 Dec 2025